Related Experiment Video
Updated: Aug 9, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Mycobacterial skin disease: approaches to therapy
G S Gart1, G J Forstall, K J Tomecki
1Department of Dermatology, Cleveland Clinic Foundation, OH 44195.
Mycobacteria cause various skin diseases, including those from Mycobacterium tuberculosis and Mycobacterium leprae. Treatment typically involves chemotherapy, with surgery sometimes beneficial for atypical mycobacterial infections.
Area of Science:
- Dermatology
- Infectious Diseases
- Microbiology
Background:
- Mycobacteria are a diverse group of bacteria known to cause significant human diseases.
- Cutaneous manifestations are a common presentation of various mycobacterial infections.
Purpose of the Study:
- To summarize the clinical presentation and management of skin diseases caused by mycobacteria.
- To highlight the role of chemotherapy and surgery in treating these infections.
Main Methods:
- Review of clinical cases and current literature on mycobacterial skin infections.
- Analysis of treatment outcomes for chemotherapy and surgical interventions.
Main Results:
- Mycobacterium tuberculosis, Mycobacterium leprae, and atypical mycobacteria are key pathogens causing skin disease.
- Chemotherapy is the primary treatment modality for most mycobacterial skin infections.
- Surgical intervention can be a valuable adjunct in managing certain atypical mycobacterial infections.
Conclusions:
- Mycobacterial skin infections require prompt diagnosis and appropriate antimicrobial therapy.
- Treatment strategies should be tailored to the specific mycobacterial species and clinical presentation.
- A multidisciplinary approach may be necessary for optimal patient outcomes.
More Related Videos
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
10:24Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells
Published on: May 22, 2026
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Staphylococcal Skin Infections
Clinical Significance of Antibiotic Resistance